Spectrum Pharma (SPPI) Misses Q1 EPS by 1c

Spectrum Pharma (NASDAQ: SPPI) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $48 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery